Supply Costs

The DeviceTalks Tuesday webinar explores how three companies handled challenges from the pandemic’s early days and discusses where each finds itself now. They also looked toward the future as hospitals resume elective surgeries that had been put on hold.

The fourth installment in the 'Bronchoscopy During COVID-19' series explores some important patient safety and financial considerations to take into account during these economically uncertain times brought on by SARS-CoV-2.

Endoscopy is part of the problem – a survey of doctors, nurses, and technicians found that most are unaware of the correct protocol for disposing accessories, including those used to take samples during a bronchoscopy.

Many hospital-acquired infections are caused by antimicrobial-resistant bacteria, and require intense antibiotic treatment. Should comprehensive antimicrobial stewardship programs include proper infection prevention protocols for handling and using devices like bronchoscopes?

Intubation and airway management during lung-isolation procedures pose a series of challenges for even the most experienced medical team. A new study shows how hospitals can save money using Ambu’s sterile, single-use product.

Percutaneous dilatational tracheostomy, or PDT, is considered a practical, safe and cost-effective alternative to open surgical tracheostomy, and both reusable and single-use bronchoscopes are suitable for the procedure. But single-use devices save money and eliminate contamination concerns.

A variety of policies, practices and products at hospitals makes it difficult to ensure that bronchoscope reprocessing is done correctly and in a timely manner, every time. Alternatives are not only economical but critical to improving quality and ensuring patient safety.

Total reprocessing time at one hospital was more than double the time at another site, but that wasn’t entirely due to an emphasis on quality. Rather, problems with water flow meant sinks took longer to fill and increased the time needed for leak tests and manual cleaning.

A new study found that sterilizing bronchoscopes took 46 minutes longer than the high-level disinfection steps used in reprocessing, and the machines used by hospitals ranged from $116,000 to $135,000, far more on average than capital outlays for automated endoscope reprocessors.

New research quantifies how much more hospitals pay to disinfect and reuse bronchoscopes rather than purchasing single-use instruments and builds on a study last year examining the effectiveness of cleaning processes used for reusable bronchoscopes.